Research laboratories around the world are now adopting our platform for a wide range of single-cell applications from tumor profiling to stem cells to embryo development to the identification and validation of new drug targets. Founded by leading scientists at Harvard University, we are based in Cambridge, MA, and we support our growing number of customers through a team of international sales and field application scientists.

Allon's research addresses the question of how stem cells choose between alternative fates in developing and adult tissues. The work in his lab focuses on the stem cells that maintain adult tissues such as the skin, and more recently on embryonic stem cells. More information on the Klein Lab

Dr. Kirschner's laboratory investigates three broad, diverse areas: regulation of the cell cycle, the role of cytoskeleton in cell morphogenesis, and mechanisms of establishing the basic vertebrate body plan.More information on the Kirschner Lab ›

Dr. Weitz is the co-director of the BASF Advanced Research Initiative at Harvard, co-director of the Harvard Kavil Institute for BioNano Science & Technology, and Director of the Harvard Materials Research Science & Engineering Center.More information on the Weitz Lab ›

Dr. Brenan is a serial life sciences entrepreneur and senior executive with 30 years experience in scientific research, project management, product development, strategic marketing and financing of early-stage life science companies. He is the founder several life science companies (HiFiBiO SAS, BioTrove Inc), formerly the Managing Director of the Monsanto-Atlas Seed Fund Alliance at Atlas Ventures and prior to Atlas, the Director of Strategic Relationships for the Center for Integration of Medicine and Innovative Technology (CIMIT).

Mr. Dom is a serial entrepreneur with expertise in private capital investment and operations. He is the founder of several life science companies (HiFiBiO SAS, Flexgen BV) and prior to FlexGen, CEO and co-founder of RSP Technology BV, a world-leading supplier of aluminum superalloys to the defense, automotive, aerospace and electronics industries.

Dr. Brenan is a serial life sciences entrepreneur and senior executive with 30 years experience in scientific research, project management, product development, strategic marketing and financing of early-stage life science companies. He is the founder several life science companies (HiFiBiO SAS, BioTrove Inc), formerly the Managing Director of the Monsanto-Atlas Seed Fund Alliance at Atlas Ventures and prior to Atlas, the Director of Strategic Relationships for the Center for Integration of Medicine and Innovative Technology (CIMIT).

Mr. Kopczynski has led product development, sales, customer support and marketing efforts at molecular diagnostics, instrumentation, assay/consumables, and informatics companies. Recent efforts with PrimeraDx, RainDance Technologies and BioTrove have concentrated on understanding customer needs and directing the development of products and services to enable their success. Mike received his BS in Biology from the Massachusetts Institute of Technology.

Dr. Bond has 30 years of experience in scientific research, product development and commercial strategy with a focus on building early-stage life science companies. Prior to 1CellBio, Andrew was Senior Director of Strategy at Gen9, a synthetic biology company, where he was responsible for driving new products and identifying key opportunities for their high-throughput gene synthesis technology. Andrew received his PhD in molecular genetics from the University of Massachusetts Medical School.

Dr. Weitz is the co-director of the BASF Advanced Research Initiative at Harvard, co-director of the Harvard Kavil Institute for BioNano Science & Technology, and Director of the Harvard Materials Research Science & Engineering Center.More information on the Weitz Lab ›

Dr. Brenan is a serial life sciences entrepreneur and senior executive with 30 years experience in scientific research, project management, product development, strategic marketing and financing of early-stage life science companies. He is the founder several life science companies (HiFiBiO SAS, BioTrove Inc), formerly the Managing Director of the Monsanto-Atlas Seed Fund Alliance at Atlas Ventures and prior to Atlas, the Director of Strategic Relationships for the Center for Integration of Medicine and Innovative Technology (CIMIT).